Authors and Affiliates
Gregory W. Roloff, MD1; Ibrahim Aldoss, MD2 ; Noam E. Kopmar, MD3 ; Chenyu Lin, MD4 ; Simone E. Dekker, MD, PhD5;
Vishal K. Gupta, MD6 ; Timothy E. O’Connor, MD7; Nikeshan Jeyakumar, MD8; Ibrahim N. Muhsen, MD9 ; Yannis Valtis, MD10 ;
Naveed Ahmed, DO10; Amy Zhang, MPH8; Katharine Miller, PhD, MPH8 ; Kaitlyn C. Dykes, MD11; Mohamed Ahmed, MD12; Evan C. Chen, MD13 ;
Santiago Mercadal, MD14 ; Marc Schwartz, MD15; Sean I. Tracy, MD, PhD16 ; Bhagirathbhai Dholaria, MBBS17 ; Akash Mukherjee, MD18;
Minoo Battiwalla, MD, MS19 ; Aaron C. Logan, MD, PhD20 ; Abdullah Ladha, MD21 ; Caitlin Guzowski, MBA22; Rasmus T. Hoeg, MD23;
Talal Hilal, MBBCh24 ; Jozal Moore, MD25; Matthew P. Connor, MD26 ; LaQuisa C. Hill, MD27 ; Stephanie B. Tsai, MD7;
Joshua P. Sasine, MD, PhD12 ; Melhem M. Solh, MD22 ; Vamsi K. Kota, MD28 ; Divya Koura, MD11; Muthu Veeraputhiran, MD18;
Jessica T. Leonard, MD5; Noelle V. Frey, MD, MS26 ; Jae H. Park, MD10 ; Marlise R. Luskin, MD, MSCE13 ; Veronika Bachanova, MD, PhD16;
Ahmed Galal, MD4; Vinod Pullarkat, MD2; Wendy Stock, MD1 ; Ryan D. Cassaday, MD3 ; Bijal D. Shah, MD, MS29; Rawan Faramand, MD29; and
Lori Muffly, MD, MS8 ; on behalf of the ROCCA Consortium
1Section of Hematology/Oncology, Department of Medicine, University
of Chicago, Chicago, IL
2Division of Leukemia, Department of Hematology and Hematopoitic
Cell Transplantation, City of Hope National Medical Center, Duarte, CA
3Division of Hematology and Oncology, Department of Medicine,
University of Washington School of Medicine, Seattle, WA
4Division of Hematologic Malignancies and Cellular Therapy, Duke
University School of Medicine, Durham, NC
5Division of Hematology-Oncology, Knight Cancer Institute, Oregon
Health & Science University, Portland, OR
6Division of Hematology & Oncology, University of California Los
Angeles, Los Angeles, CA
7Division of Hematology/Oncology, Cardinal Bernardin Cancer Center,
Loyola University Medical Center, Maywood, IL
8Division of Blood and Marrow Transplantation and Cellular Therapy,
Stanford University, Stanford, CA
9Section of Hematology and Oncology, Department of Medicine, Baylor
College of Medicine, Houston, TX
10Memorial Sloan Kettering Cancer Center, New York, NY
11Department of Medicine, Division of Hematology and Oncology,
University of California San Diego Moores Cancer Center, San Diego, CA
12Cedars-Sinai Medical Center, Los Angeles, CA
13Adult Leukemia Program, Dana-Farber Cancer Institute, Boston, MA
14Transplant and Cellular Therapy Program, Huntsman Cancer Institute,
University of Utah, Salt Lake City, UT
15University of Colorado Anschutz School of Medicine, Aurora, CO
16Division of Hematology, Oncology and Transplantation, University of
Minnesota, Minneapolis, MN
17Division of Hematology and Oncology, Department of Medicine,
Vanderbilt University Medical Center, Nashville, TN
18University of Arkansas Medical Center, Little Rock, AK
19Sarah Cannon Transplant and Cell Therapy Network, Nashville, TN
20Department of Medicine, Division of Hematology and Blood and
Marrow Transplantation, University of California, San Francisco, CA
21Department of Hematology, Norris Cancer Center, University of
Southern California, Los Angeles, CA
22Blood and Marrow Transplant Program, Northside Hospital, Atlanta,
GA
23Department of Internal Medicine, Division of Hematology and
Oncology, University of California Davis School of Medicine,
Sacramento, CA
24Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix,
AZ
25Division of Hematology/Oncology, Department of Medicine, James P.
Wilmot Cancer Institute, University of Rochester Medical Center,
Rochester, NY
26Division of Hematology-Oncology, Department of Medicine, University
of Pennsylvania, Philadelphia, PA
27Center for Cell and Gene Therapy, Baylor College of Medicine and
Houston Methodist Hospital, Houston, TX
28Georgia Cancer Center, Augusta University, Augusta, GA
29Moffitt Cancer Center, Tampa, FL
